A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities.
about
Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3The cystine knot promotes folding and not thermodynamic stability in vascular endothelial growth factorFOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1Structural determinants of growth factor binding and specificity by VEGF receptor 2A model for gene therapy of human hereditary lymphedemaVascular endothelial growth factor and the in vivo increase in plasma extravasation in the hamster cheek pouchCharacterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2Characterization of novel VEGF (vascular endothelial growth factor)-C splicing isoforms from mouseNFATc1 regulates lymphatic endothelial developmentVEGF guides angiogenic sprouting utilizing endothelial tip cell filopodiaGeneChip analysis of human embryonic stem cell differentiation into hemangioblasts: an in silico dissection of mixed phenotypes.Molecular cloning and expression of a functional snake venom vascular endothelium growth factor (VEGF) from the Bothrops insularis pit viper. A new member of the VEGF family of proteins.Tumour vascularization: sprouting angiogenesis and beyondSuppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axisPhage-derived fully human monoclonal antibody fragments to human vascular endothelial growth factor-C block its interaction with VEGF receptor-2 and 3.The vascular endothelial growth factor family: signalling for vascular development.Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea.Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis.Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation.Molecular characterization of lymphatic endothelial cells.Temporal and spatial regulation of epsin abundance and VEGFR3 signaling are required for lymphatic valve formation and functionLymphatic endothelium: a new frontier of metastasis research.Effects of LDL Receptor Modulation on Lymphatic FunctionExperimental assessment of pro-lymphangiogenic growth factors in the treatment of post-surgical lymphedema following lymphadenectomy.Vascular endothelial growth factor receptors: molecular mechanisms of activation and therapeutic potentials.Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1Generation and characterization of telomerase-transfected human lymphatic endothelial cells with an extended life spanVascular endothelial growth factor-C accelerates diabetic wound healingVascular endothelial growth factor-D is a key molecule that enhances lymphatic metastasis of soft tissue sarcomasDistinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting.Lymphangiogenic gene therapy with minimal blood vascular side effectsThe role of the VEGF-C/VEGFRs axis in tumor progression and therapy.Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumoursAngiogenesis in cancer.Non-invasive dynamic near-infrared imaging and quantification of vascular leakage in vivo.Functional Importance of a Proteoglycan Coreceptor in Pathologic LymphangiogenesisEndothelial nitric oxide synthase mediates lymphangiogenesis and lymphatic metastasis.Inhibition of the focal adhesion kinase and vascular endothelial growth factor receptor-3 interaction leads to decreased survival in human neuroblastoma cell lines.Novel vascular endothelial growth factor D variants with increased biological activityVascular endothelial growth factors C and D induces proliferation of lymphangioleiomyomatosis cells through autocrine crosstalk with endothelium.
P2860
Q24291630-32668A8F-E3C3-4BD8-B3B5-A71A5C2D53B1Q24305927-BA014A06-6037-44B6-A609-455A940CA62DQ24641842-0C99FD1B-2159-455E-8591-05D8A20D7B66Q27659686-3CFD8A4A-C47C-43DF-B95F-8481D5EDE8A0Q28191040-6FBDA8D8-DCC5-47BF-B8D5-5B63C49C2D48Q28360225-EA3D6D53-4AFD-43E1-BB53-E54772A016CCQ28580820-4F150970-B1F7-4F3F-824E-9F582D8F87B7Q28588181-A9B056C7-BCF8-4D9B-B45B-DEFF517DAF7DQ28593523-1EAB1702-DB48-4F1C-BF52-DF5404BF8892Q29617501-65B39DC4-1C19-4670-A9CF-15269F208C70Q30481349-BA292684-9E64-4366-B234-01162A9B649CQ30702674-E6A63648-849E-46F4-9A14-D0CD551F7823Q33556162-6BA4D117-1BC5-480A-A8ED-50E01E3C1CE7Q33565805-7C6C41F3-15C3-4499-9122-3FDEC6AD6C55Q33651167-29140BD9-6A15-472B-91C7-9E6E0864E461Q33737967-F82D50B6-98F1-43ED-8C2C-223AB4D6DDBFQ34066152-91B866AC-E63C-4364-AA54-36C729234E3AQ34130552-1DC3A277-5D8B-465F-8382-D6DDA1D2E80EQ34161479-040F5D8F-FCB6-4561-B944-209B1B758FEAQ34415420-713EADF2-8730-4E7B-BE63-552DA75DF70DQ34483937-E0519B2D-89CF-4DDA-8683-BE576472F0BAQ34486406-41657D7B-1789-4F4B-B864-BD190AE2A850Q34530204-073DE1FC-99E8-4FFF-BBF0-99986CC8CAC2Q34989014-8BA15618-2391-47C4-8ECE-B30F032A59E4Q35049227-6DEA8494-CDEC-494A-8C47-34A4135A8989Q35065442-8E404F17-5E44-4B6A-A199-1A4022AA7EF7Q35102884-5A5331CA-F52F-47E6-908F-AFD59A1CE596Q35222023-49A42780-55DA-40B4-BF11-EAA2C5419EDAQ35836386-CCE06781-9CBD-40B2-86E8-C8D4481D691AQ36229454-B172866A-2964-4CDA-B2B6-D4D96D148DD1Q36371262-BC5EE7BD-8328-4D22-A698-51BF6DC2BBD5Q36589860-A66340EE-6BB1-4EAB-B64C-EAE99E041230Q36671549-81BCBA1B-84A6-4095-AF58-CF13FA0D1270Q36746626-276D67E6-3CEA-4C32-97EF-C3FF071B2DF1Q37020622-71A036E4-123B-4C35-BA11-4D4B9DA367FEQ37079690-82E77417-E690-45BF-8899-8E7A1E900702Q37161838-18D57D12-1CA9-4EDC-8F50-46B5C7155D3AQ37257170-9A0C3FEB-1525-479E-BB17-2823972394CDQ37257420-4D794D06-B400-406A-A585-D725917A385BQ37362046-A6FF0D2D-A276-43CC-B418-E571E132F151
P2860
A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
A recombinant mutant vascular ...... cular permeability activities.
@en
type
label
A recombinant mutant vascular ...... cular permeability activities.
@en
prefLabel
A recombinant mutant vascular ...... cular permeability activities.
@en
P2093
P356
P1476
A recombinant mutant vascular ...... cular permeability activities.
@en
P2093
P304
P356
10.1074/JBC.273.12.6599
P407
P50
P577
1998-03-01T00:00:00Z